QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jarrod W. Pakosh who wrote (775)	11/26/1999 10:55:00 AM
From: BostonView	Read Replies (1) of 1321

Travelling to the West coast for the holiday on Wednesday, I was leafing through my in-flight copy of USA Today. It had a full page article on QLTI's "other" drug for esophogous (sp?) cancer. It focused more on the history of the drug, cost of development (justifying it's expense), and how QLTI came to own the rights. Interesting read, and more good exposure for the company. Happy Thanksgiving, all BV

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next